Search Results
ATMP guidance
Confidence at every stage With complexity and risk associated with each stage of assay development, our Advanced Therapy Medicinal Products (ATMP) best practice guidance offers a practical and phase-a…
Uploaded: 10 February, 2026
Key Insights: A guide to the ‘More Resources’ tab
Published 30 January 2026 We are pleased to announce the return of the Key Insights series, publishing at regular monthly intervals. In this article, we are sharing insights into the ‘More Resources’…
Uploaded: 30 January, 2026
Proposed monographs for omission from the BP 2027
Published 23 January 2026 The British Pharmacopoeia Commission is continuing to ensure that the publication remains relevant and comprehensive. As part of this work, several monographs included in the…
Uploaded: 29 January, 2026
Privacy Policy
MHRA PRIVACY NOTICE At the Medicines and Healthcare products Regulatory Agency (the Agency) we are committed to protecting and respecting your privacy. This privacy notice describes how the MHRA colle…
Uploaded: 14 January, 2026
The BP would like your views on newly published draft texts
Published 12 January 2026 We are pleased to announce the first public consultation and feedback period of the year for new and revised draft texts is now open and will close on 31 March 2026. All draf…
Uploaded: 12 January, 2026
The British Pharmacopoeia (BP) 2026 edition is now legally effective
Published 2 January 2026 The British Pharmacopoeia (BP) 2026 edition from the Medicines and Healthcare products Regulatory Agency (MHRA) supersedes the BP 2025 and is now legally effective. It includ…
Uploaded: 2 January, 2026
Ph. Eur. Issue 12.2 is now available online and to download
Published 19 December 2025 The content of the European Pharmacopoeia (Ph. Eur.) Issue 12.2 is now available as part of the British Pharmacopoeia (BP) 2026 online edition. You can access this in-year u…
Uploaded: 19 December, 2025
The British Pharmacopoeia 2026 edition becomes legally effective 1 January 2026
Published 11 November 2025 The British Pharmacopoeia (BP) 2026 edition from the Medicines and Healthcare products Regulatory Agency (MHRA) becomes legally effective from 1 January 2026. Essential in e…
Uploaded: 12 December, 2025
British Pharmacopoeia at the JPAG Hot Topics Meeting
Published 12 December 2025 Earlier this month, Peter Crowley, Editor-in-Chief of the British Pharmacopoeia (BP), addressed the 10th annual Hot Topics meeting of the Joint Pharmaceutical Analysis Group…
Uploaded: 12 December, 2025
About the BAN
The British Approved Name (BAN) is a unique name assigned to a pharmaceutical substance by the British Pharmacopoeia Commission (BPC) to ensure standardisation and clarity in drug nomenclature. The BP…
Uploaded: 24 November, 2025